Insider Selling: Privia Health Group (NASDAQ:PRVA) EVP Sells 4,949 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) EVP Edward Fargis sold 4,949 shares of the business’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $22.84, for a total transaction of $113,035.16. Following the completion of the sale, the executive vice president owned 83,711 shares of the company’s stock, valued at approximately $1,911,959.24. This represents a 5.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Privia Health Group Stock Down 3.6%

Shares of NASDAQ PRVA traded down $0.83 during midday trading on Tuesday, reaching $22.47. 1,025,433 shares of the company’s stock traded hands, compared to its average volume of 813,068. The company has a market cap of $2.78 billion, a price-to-earnings ratio of 132.18, a P/E/G ratio of 1.49 and a beta of 0.82. The stock’s 50 day simple moving average is $23.03 and its 200-day simple moving average is $23.60. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The company had revenue of $541.17 million during the quarter, compared to analyst estimates of $516.61 million. During the same quarter in the prior year, the business earned $0.21 earnings per share. Privia Health Group’s revenue was up 17.4% on a year-over-year basis. Equities analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have commented on PRVA. BMO Capital Markets began coverage on shares of Privia Health Group in a research report on Thursday, November 13th. They set an “outperform” rating and a $30.00 price target for the company. Royal Bank Of Canada started coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 price objective for the company. Stephens reissued an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday, December 4th. Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, February 27th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research report on Monday, December 29th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $31.00.

Institutional Trading of Privia Health Group

A number of institutional investors have recently bought and sold shares of PRVA. Bayban purchased a new stake in Privia Health Group during the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. raised its holdings in shares of Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after buying an additional 926 shares during the last quarter. Global Retirement Partners LLC lifted its stake in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after buying an additional 1,351 shares during the period. Canada Pension Plan Investment Board lifted its stake in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC purchased a new stake in shares of Privia Health Group during the fourth quarter valued at $93,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.